95 related articles for article (PubMed ID: 20013612)
1. Fas ligand (FasL, Apo-1L/CD95L) expression and clinical outcome in papillary microcarcinoma and papillary thyroid carcinomas with diameter smaller than 1.5 centimeters.
Bayraktaroglu T; Boztepe H; Kapran Y; Tanakol R; Alagöl F
Exp Clin Endocrinol Diabetes; 2010 Aug; 118(8):537-43. PubMed ID: 20013612
[TBL] [Abstract][Full Text] [Related]
2. Papillary microcarcinoma of the thyroid.
Shaha AR; Tuttle RM; Shah JP
J Surg Oncol; 2007 Jun; 95(7):532-3. PubMed ID: 17192917
[No Abstract] [Full Text] [Related]
3. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy.
Vassilopoulou-Sellin R; Schultz PN; Haynie TP
Cancer; 1996 Aug; 78(3):493-501. PubMed ID: 8697396
[TBL] [Abstract][Full Text] [Related]
5. [Thyroid papillary microcarcinoma. Salah Azaiz Institute experience].
Oueslati Z; Aloui M; Gritli S; Touati S; el-May A; Gamoudi A; Ben-Slimene F; Ladgham A
Rev Laryngol Otol Rhinol (Bord); 2002; 123(1):39-42. PubMed ID: 12200999
[TBL] [Abstract][Full Text] [Related]
6. Current perspectives on papillary carcinoma of the thyroid gland.
Chiu MK; Sherry RM; Wei JP
J Med Assoc Ga; 1992 Aug; 81(8):442-4. PubMed ID: 1512532
[TBL] [Abstract][Full Text] [Related]
7. Galectin-3 expression in papillary microcarcinoma of the thyroid.
Cvejic D; Savin S; Petrovic I; Paunovic I; Tatic S; Krgovic K; Havelka M
Histopathology; 2005 Aug; 47(2):209-14. PubMed ID: 16045783
[TBL] [Abstract][Full Text] [Related]
8. Outcome after treatment of papillary thyroid microcarcinoma.
Appetecchia M; Scarcello G; Pucci E; Procaccini A
J Exp Clin Cancer Res; 2002 Jun; 21(2):159-64. PubMed ID: 12148571
[TBL] [Abstract][Full Text] [Related]
9. High recurrent rate of multicentric papillary thyroid carcinoma.
Lin JD; Chao TC; Hsueh C; Kuo SF
Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
[TBL] [Abstract][Full Text] [Related]
10. Radioiodine therapy for papillary and follicular thyroid carcinoma.
Klain M; Ricard M; Leboulleux S; Baudin E; Schlumberger M
Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S479-85. PubMed ID: 12192549
[TBL] [Abstract][Full Text] [Related]
11. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics of poorly differentiated thyroid carcinomas compared with those of classical papillary thyroid carcinomas.
Lin JD; Chao TC; Hsueh C
Clin Endocrinol (Oxf); 2007 Feb; 66(2):224-8. PubMed ID: 17223992
[TBL] [Abstract][Full Text] [Related]
13. What is the biology and optimal treatment for papillary microcarcinoma of the thyroid?
Cheema Y; Olson S; Elson D; Chen H
J Surg Res; 2006 Aug; 134(2):160-2. PubMed ID: 16780882
[TBL] [Abstract][Full Text] [Related]
14. Experience in the management of thyroid carcinoma by I-131. A report of 39 cases.
Bricout P; Kibler RS
J Can Assoc Radiol; 1973 Dec; 24(4):323-7. PubMed ID: 4773908
[No Abstract] [Full Text] [Related]
15. [Total thyroidectomy of choice in papillary microcarcinoma].
Pisello F; Geraci G; Sciumè C; Li Volsi F; Modica G
G Chir; 2007; 28(1-2):13-9. PubMed ID: 17313727
[TBL] [Abstract][Full Text] [Related]
16. The coexistence of anaplastic and papillary carcinomas of the thyroid: a case presentation and literature review.
Fortson JK; Durden FL; Patel V; Darkeh A
Am Surg; 2004 Dec; 70(12):1116-9. PubMed ID: 15663057
[TBL] [Abstract][Full Text] [Related]
17. Expression of syndecan-1 in papillary carcinoma of the thyroid with extracapsular invasion.
Bologna-Molina R; González-González R; Mosqueda-Taylor A; Molina-Frechero N; Damián-Matsumura P; Dominguez-Malagón H
Arch Med Res; 2010 Jan; 41(1):33-7. PubMed ID: 20430252
[TBL] [Abstract][Full Text] [Related]
18. Papillary microcarcinoma of the thyroid gland: analysis of prognostic factors including histological subtype.
Falvo L; D'Ercole C; Sorrenti S; D'Andrea V; Catania A; Berni A; Grilli P; De Antoni E
Eur J Surg Suppl; 2003 Jul; (588):28-32. PubMed ID: 15200040
[TBL] [Abstract][Full Text] [Related]
19. [Simultaneous papillary carcinoma in a thyroglossal duct remnant and the thyroid gland].
Lehnerdt KH; Mehlhorn J; Nürnberger H; Deitmer T
Laryngorhinootologie; 2006 Dec; 85(12):909-12. PubMed ID: 16586292
[TBL] [Abstract][Full Text] [Related]
20. [Differentiated microcarcinoma of the thyroid gland].
Sorrentino F; Atzeni J; Romano G; Buscemi G; Romano M
G Chir; 2010; 31(6-7):277-8. PubMed ID: 20646369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]